Fluid and electrolyte management in preterm infants with patent ductus arteriosus

J Neonatal Perinatal Med. 2022;15(4):689-697. doi: 10.3233/NPM-210943.

Abstract

Optimal fluid management of preterm babies with suspected or confirmed diagnosis of patent ductus arteriosus (PDA) is frequently challenging for neonatal care physician because of paucity of clinical trials. There is wide variation in practice across neonatal units, resulting in significant impact on outcomes in Extremely Low Birth Weight (ELBW) babies with hemodynamically significant PDA. A delicate balance is required in fluid management to reduce mortality and morbidity in this population. The purpose of this review is to lay out the current understanding about fluid and electrolyte management in ELBW babies with hemodynamically significant PDA and highlight areas for future research.

Keywords: Diuretics; electrolytes; fluid management; patent ductus arteriosus; preterm neonates.

Publication types

  • Review

MeSH terms

  • Ductus Arteriosus, Patent* / drug therapy
  • Electrolytes / therapeutic use
  • Humans
  • Infant, Extremely Low Birth Weight
  • Infant, Newborn
  • Infant, Premature
  • Persistent Fetal Circulation Syndrome*

Substances

  • Electrolytes